Year-over-year earnings per share growth for the last twelve months: empro.my (EMPG)

EMPG (Empro Group Inc.) - company brandmark

Empro Group Inc (EMPG) maintains its position through the active promotion of its personal brand in Malaysia. The quarterly EPS change on GURU.Markets reflects a financial result where the indicator stands at 0.00. Revenues are based on the sale of cosmeceuticals in Southeast Asia. Meanwhile, formula patents create a defensive barrier, which is partially offset by consumers' ease of switching cosmetic brands.

Empro Group (EMPG) - Earnings per share growth in annualized terms for the last twelve months from 07/03/2025 to 10/25/2025
Manufactured product of Empro Group Inc

Quarterly EPS growth measures the dynamics of net profit per share, reflecting capital generation efficiency and the business's operational resilience over the short term. For Empro Group Inc (EMPG), the quarterly EPS evolution serves as an indicator of stability in Southeast Asia, where the absence of sanction risks allows for an assessment of the company's fundamental growth without geopolitical distortions.

Analysis of competing companies

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics Inc|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel Inc.)|Quarterly EPS earnings growth ORKA|SMTI - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months DBV Technologies DBVT|SLSN - Year-over-year net earnings per share growth for the last 12 months|DERM - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months FBRX|Sol-Gel Technologies (SLGL) - Year-over-year earnings per share growth for the last twelve months|AXIL Brands - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Medicus Pharma|Earnings per share growth in annualized terms for the last twelve months Verrica VRCA|Year-over-year net earnings per share growth for the last 12 months HOTH (Hoth Therapeutics, Inc.)|BFRI (biofrontera-us.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth VYNE (VYNE Therapeutics Inc.)|Net earnings per share growth for the trailing year Sonoma Pharmaceuticals Inc.|QNRX - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months AZTR (Azitra Inc)|Dermata (DRMA) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Elevai Corp (ELAB)|Year-over-year net earnings per share growth for the last 12 months RVNC